Switching to subcutaneous administration may offer more profound remission compared to intensified intravenous therapy in patients with inflammatory bowel disease and partial response following induction with intravenous vedolizumab: the PRIVEDO stud
In IBD patients with partial response to IV VDZ induction, switching to SC VDZ may lead to more profound remission than continuing IV optimization.
Authors
- Filippo Mocciaro (ORCID: https://orcid.org/0000-0002-4389-0643)
- Ambrogio Orlando (ORCID: https://orcid.org/0000-0002-5298-2638)
- Walter Fries (ORCID: https://orcid.org/0000-0001-6159-7478)
- G. Mistretta
- Samantha L. Morello (ORCID: https://orcid.org/0000-0001-5209-051X)
- Sara Renna
- B. Scrivo (ORCID: https://orcid.org/0000-0002-0329-9488)
- Mauro Grova (ORCID: https://orcid.org/0000-0001-8978-8604)
- Raffaele Li Voti
- Fabio Salvatore Macaluso (ORCID: https://orcid.org/0000-0001-5128-3846)
- Concetta Ferracane
- Emiliano Giangreco
- P Melatti
- Angelo Casà
- Anna Viola (ORCID: https://orcid.org/0000-0002-1733-6489)
- Maria Giovanna Minissale
- Simona Di
- Maria Cappello
- Stefano Muscarella (ORCID: https://orcid.org/0009-0009-6223-2513)
- Samuele Armetta
Institutions
- Ospedale Vincenzo Cervello (IT)
- Ospedale Sant Antonio (IT)
- Hospital Universitario Araba (ES)
- University of Palermo (AR)
- Azienda Ospedaliera Universitaria Policlinico "G. Martino" (IT)
- Azienda di Rilievo Nazionale ed Alta Specializzazione (IT)
- Azienda Ospedaliero Universitaria Policlinico "G.Rodolico - San Marco" (IT)
- Ospedale Buccheri la Ferla Fatebenefratelli (IT)
- University of Palermo (IT)
Publication Details
- Journal
- Journal of Crohn s and Colitis
- Published
- 2025-09-27
- DOI
- https://doi.org/10.1093/ecco-jcc/jjaf175
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00